| Patient | Age (y) | Sex | Sample | Method | Variant | Alt.var.freq% (wt;alt) |
|---|---|---|---|---|---|---|
| GLA002 | 17 | F | GLA002-Bone1 (iliac crest) | HB | − | 0 (186;0) |
| GLA002-Bone2 (sacrum) | AB | −a | 0.01 (38,548;5) | |||
| GLA002-Fascia tissue | AB | −a | 0.02 (34,032;6) | |||
| GLA002-LM (FFPE) | AB | c.3140A>G; p.His1047Arg | 23.0 (22,652;6,761) | |||
| GLA006 | 23 | M | GLA006-LM_1 | HB | − | 0 (277;0) |
| GLA006-LM_2 (FFPE) | AB | c.3140A>T; p.His1047Leu | 18.48 (12,007;2,722) | |||
| GLA011 | 20 | M | GLA011-LM | AB | − | − |
| GLA022 | 6 | F | GLA022-LM (FFPE) | AB | − | − |
| GLA038 | 15 | F | GLA038-LM | AB | − | − |
| GLA051 | 35 | F | GLA051-LM | HB | c.1624G>A; p.Glu542Lys | 3.5 (320;11) |
| GLA051-LM | AB | c.1624G>A; p.Glu542Lys | 1.1 (35,018;385) | |||
| GLA053 | 4 | M | GLA053-LM | AB | − | − |
| GLA054 | 38 | F | GLA054-LM | HB | c.1636C>A; p.Gln546Lys | 3.1 (624;20) |
| GLA054-LM | AB | c.1636C>A; p.Gln546Lys | 3.4 (51,752;1,780) | |||
| GLA054-LM-LECs | HB | c.1636C>A; p.Gln546Lys | 27.9 (277;107) | |||
| GLA061 | 16 | M | GLA061-LM | AB | c.1624G>A; p.Glu542Lys | 1.68 (73,577;1,234) |
| GLA061-LM-LECs | AB | c.1624G>A; p.Glu542Lys | 33.67 (36,999;12,459) |
| Patient | Age (y) | Sex | Sample | Method | Variant | Alt.var.freq% (wt;alt) |
|---|---|---|---|---|---|---|
| GLA002 | 17 | F | GLA002-Bone1 (iliac crest) | HB | − | 0 (186;0) |
| GLA002-Bone2 (sacrum) | AB | − | 0.01 (38,548;5) | |||
| GLA002-Fascia tissue | AB | − | 0.02 (34,032;6) | |||
| GLA002-LM (FFPE) | AB | c.3140A>G; p.His1047Arg | 23.0 (22,652;6,761) | |||
| GLA006 | 23 | M | GLA006-LM_1 | HB | − | 0 (277;0) |
| GLA006-LM_2 (FFPE) | AB | c.3140A>T; p.His1047Leu | 18.48 (12,007;2,722) | |||
| GLA011 | 20 | M | GLA011-LM | AB | − | − |
| GLA022 | 6 | F | GLA022-LM (FFPE) | AB | − | − |
| GLA038 | 15 | F | GLA038-LM | AB | − | − |
| GLA051 | 35 | F | GLA051-LM | HB | c.1624G>A; p.Glu542Lys | 3.5 (320;11) |
| GLA051-LM | AB | c.1624G>A; p.Glu542Lys | 1.1 (35,018;385) | |||
| GLA053 | 4 | M | GLA053-LM | AB | − | − |
| GLA054 | 38 | F | GLA054-LM | HB | c.1636C>A; p.Gln546Lys | 3.1 (624;20) |
| GLA054-LM | AB | c.1636C>A; p.Gln546Lys | 3.4 (51,752;1,780) | |||
| GLA054-LM-LECs | HB | c.1636C>A; p.Gln546Lys | 27.9 (277;107) | |||
| GLA061 | 16 | M | GLA061-LM | AB | c.1624G>A; p.Glu542Lys | 1.68 (73,577;1,234) |
| GLA061-LM-LECs | AB | c.1624G>A; p.Glu542Lys | 33.67 (36,999;12,459) |
AB, amplicon-based high-throughput sequencing; Alt.var.freq%, frequency of the alternative variant; F, female; HB, hybridization-based; M, male; wt;alt, number of reads for wild-type and alternative alleles.
Next-generation sequencing reads in the background noise range of the technique and cannot be considered as positive.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.